Hana Asset Management Donates 25 Million Won to Cheongsonyeon Geuruteogi Foundation Using "ETF Management Fees"

Event Marking the Third Anniversary of Its Launch
Donation Made from Management Fees of the 1Q U.S. Medical AI ETF

Hana Asset Management said on the 11th that it donated 25 million won to the Cheongsonyeon Geuruteogi Foundation at an event held on the 2nd to mark the third anniversary of its launch. The donation will support treatment and rehabilitation for children from vulnerable backgrounds.

The donation was funded with 10% of the approximately 250 million won in cumulative management fees earned since the launch of the 1Q U.S. Medical AI ETF. The aim is to return to society some of the growth achieved together with customers and extend the value of a product that invests in medical innovation to support for children's healthcare.

Hana Asset Management donated 25 million won to the Cheongsonyeon Geurutegi Foundation at an event marking its third anniversary on the 2nd, to support treatment and rehabilitation for children from vulnerable groups. Hana Asset Management

The donation will be used through the Cheongsonyeon Geuruteogi Foundation to fund treatment and rehabilitation for children with rare and incurable diseases or from vulnerable backgrounds. Hana Asset Management said it would continue making donations as the ETF grows.

At the anniversary event, the company shared the purpose of the donation with the message, "Investing in the future of medicine and supporting a healthier tomorrow for children." A donation placard handover ceremony and commemorative photo session were also held.

At the first anniversary of its launch, Hana Asset Management also introduced the work of the Cheongsonyeon Geuruteogi Foundation, which was established and is supported by Hana Financial Group, and encouraged all employees to participate in donations. In May, it contributed 100 million won from the management fees of its 1Q U.S. Aerospace Tech ETF to the KAIST Department of Aerospace Engineering's development fund, supporting related research and development and talent development.

Kim Tae-woo, CEO of Hana Asset Management, said, "All of our employees participate in donations to the Cheongsonyeon Geuruteogi Foundation, and we are also continuing our social contribution efforts in areas related to our ETF investment themes. We want to make the third anniversary of our launch an opportunity to express gratitude for our growth and put sharing into practice."

He added, "Through this donation, we hope to help fund treatment and rehabilitation for children with rare and incurable diseases and those from vulnerable backgrounds. We will continue providing support rather than making this a one-time donation, and put Hana Financial Group's vision of 'growing together and sharing happiness through finance' into practice."

Meanwhile, the 1Q U.S. Medical AI ETF invests in changes in the healthcare industry, including diagnosis and treatment using artificial intelligence. Tracking the KEDI U.S. Medical AI Index, it focuses on 10 leading U.S. medical AI companies and seeks growth opportunities in fields such as AI-based precision medicine and drug development. Its major holdings include Tempus AI (23.8%), Moderna (21.3%), and Merck (14.1%).

This content was produced with the assistance of AI translation services.